Study Highlights More Effective and Safe Way to Deliver Chemotherapy
Dec 19, 2023
A new study, led by the University of Glasgow and published in The Lancet, has compared the three main ways anticancer treatment is given to patients when administered via a central vein. Hickman-type tunnelled catheters (Hickman), peripherally inserted central catheters (PICCs), and totally implanted ports (PORTs) are used to deliver systemic anticancer treatment (SACT) via a central vein. The researchers compared complication rates and costs of these three devices to establish acceptability, clinical effectiveness, and cost effectiveness of the devices for patients receiving this kind of treatment. The study found that for most patients receiving SACT, PORTs are more effective and safer than both Hickman and PICCs. The authors say their findings suggest that most patients receiving SACT for solid tumours should receive a PORT within the UK National Health Service. Prof Jonathan Moss, honorary professor at the Institute of Cancer Sciences, said: “Our CAVA trial compared three different devices for delivering chemotherapy for patients with cancer. This is important because delivery of chemotherapy needs to be effective and safe. Our study found that PORTs, which are the least frequently used and the most expensive, turned out to be the most effective from both an efficacy, safety and costing perspective when compared with the other two (PICC line and Hickman line).
Radiation Oncologists Met With Congressional Leaders to Reverse CMS Cuts and Provide Equal Access to Care
Radiation oncologists met with Congress to urge leaders to consider how the Medicare and Medicaid Services (CMS) proposal to make significant cuts to radiation oncology facilities could be detrimental to the survival of patients with Read more…
FDA Approves Neoadjuvant Pembrolizumab Combination for Early TNBC Indication
The FDA granted approval to the supplemental biologics license application (sBLA) for pembrolizumab (Keytruda) as neoadjuvant therapy for patients with high-risk early-stage triple-negative breast cancer (TNBC) when given in combination with chemotherapy followed by single-agent Read more…
Recommended TVUS Screening Thresholds May Miss Endometrial Cancer in Black Women
Adherence to current clinical guidelines for the evaluation of postmenopausal bleeding may result in systematic underdiagnosis of endometrial cancer (EC) in Black women, according to a study published online July 15 in JAMA Oncology. Kemi M. Read more…